This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Yet up to 90% of liver diseases are preventable through modifiable riskfactors such as diet, weight management, and physical activity. Its an immersive experience that enhances learning and strengthens crucial decision-making skills, making the process of earning CME credits both educational and enjoyable.
Themed “Decoding the Constellation of Cardiometabolic Health and RiskFactors,” this year’s congress will tackle the growing health threat posed by cardiometabolic diseases, affecting 47 million people in the US. Chair: Erin D. Michos, MD Presenters: Chiadi Ndumele, MD; Pam R. Co-Presenters: Diana Barb, MD; Mitchell L.
Updated with the latest research since the 2020 edition, this comprehensive report underscores the potential to prevent or significantly delay dementia by targeting modifiable riskfactors. The report now identifies 14 modifiable riskfactors for dementia.
Here’s what you can expect at the biggest conference in cardiorenal metabolic health, the 19th Annual Cardiometabolic Congress (CMHC), DECODING THE CONSTELLATION of Cardiometabolic Health and RiskFactors. Learn more or secure your registration by clicking here.
As a leader in the field of research-based cardiometabolic health education, CMHC is proud to present its CME education outcomes study at ADA (American Diabetes Association) 2024 Scientific Sessions, which offers its education-focused agenda to a wide number of healthcare practitioners from all areas of the U.S.
A vast collection of webinars, CME activities, expert interviews, on-demand event recordings, news articles, drug pipelines, and many other resources are now grouped into areas of specialty focus. ” Learners can see some of the CMHC experts in person on Aug.
Distinguished faculty will present comprehensive medical education designed for all healthcare professionals who treat women, enhancing their ability to identify and treat cardio-renal-metabolic conditions in women across the lifespan. Attendees will earn 11.75
When we explore the three traditional cardiometabolic riskfactors (obesity, type 2 diabetes, and dyslipidemia) and the emerging cardiometabolic riskfactor of non-alcoholic fatty liver disease, we unearth a complex interplay of societal, biological, genetic, and environmental factors. . #1
When I have a patient with obstructive coronary artery disease, I ensure they: Have all their riskfactors addressed Are on all the appropriate medications I then go over this data and am very clear about the evidence. Current Indications for Stenting: Symptoms or Survival CME. Subscribe now What do I think?
cardiometabolic health CME/CE conference: the 19th Annual CMHC. 42% of adults are considered obese , increasing their risk of diabetes, hypertension, and cardiovascular issues. Additionally, 10% of the global population suffers from chronic kidney disease , with diabetes and hypertension as significant riskfactors.
Leverage Medications with Dual Benefits : GLP-1 agonists, statins, and pioglitazone offer broad benefits for managing both MASH and cardiometabolic riskfactors. Monitor Cardiovascular Risk : Statin therapy and managing conditions like hypertension and T2D are crucial for reducing the risk of cardiovascular events in MASH patients.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content